Several healthcare and biotech stocks posted notable gains in after-hours trading on Monday, driven by earnings updates, executive appointments, and capital market activity.
Pulmonx Corp. (LUNG) surged 33.33% to $2.08 as of 9:36 PM EDT. The company announced preliminary, unaudited third-quarter 2025 revenue of about $21.5 million. Pulmonx also rescheduled its Q3 financial results release to Wednesday, November 12, 2025, after market close. In a leadership update, Glen French was reappointed as President and CEO, effective immediately, while Derrick Sung will assume the roles of COO and CFO starting November 3.
Q32 Bio Inc. (QTTB) rose 12.5% to $3.15 in after-hours trading at 7:56 PM EDT. No company-specific news was released to explain the move.
Universal Health Services Inc. (UHS) climbed 7.41% to $229.90 as of 10:21 PM EDT. The company reported its third-quarter results and revised its full-year 2025 operating forecast. Additionally, on October 27, the Board of Directors authorized a $1.5 billion increase to its stock repurchase program, signaling confidence in long-term value.
X4 Pharmaceuticals Inc. (XFOR) gained 5.35% to close at $3.94 in after-hours trading at 7:59 PM EDT. The company completed its previously announced underwritten public offering of 52.8 million shares, including the full exercise of the underwriters' option for 6.98 million additional shares. The offering also included pre-funded warrants for 700,000 shares. Gross proceeds totaled approximately $155.3 million before expenses, bringing total shares outstanding to 79.2 million.
Greenwich LifeSciences Inc. (GLSI) advanced 5.41% to $10.32 as of 6:17 PM EDT. No new developments were reported.
Cardiff Oncology, Inc. (CRDF) moved up 5.26% to $2.41 in after-hours trading at 7:56 PM EDT. The gain came without any accompanying news.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.